摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5-氨基-2-氯苯基)苯基甲酮 | 46495-60-7

中文名称
(5-氨基-2-氯苯基)苯基甲酮
中文别名
——
英文名称
5-amino-2-chlorobenzophenone
英文别名
3-Amino-6-chlorophenyl phenyl ketone;5-Amino-2-chlor-benzophenon;(5-Amino-2-chlorophenyl)(phenyl)methanone;(5-amino-2-chlorophenyl)-phenylmethanone
(5-氨基-2-氯苯基)苯基甲酮化学式
CAS
46495-60-7
化学式
C13H10ClNO
mdl
——
分子量
231.681
InChiKey
KZJVQORHPPEMBG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    416.1±30.0 °C(Predicted)
  • 密度:
    1.274±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    43.1
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (5-氨基-2-氯苯基)苯基甲酮三乙胺三氯氧磷 作用下, 以 为溶剂, 反应 0.05h, 生成 2-chloro-5-aminothiobenzophenone
    参考文献:
    名称:
    在无溶剂条件下使用PSCl 3 / H 2 O / Et 3 N系统进行微波辅助的硫磺化反应
    摘要:
    一种新的硫化协议羰基化合物,与系统PSCl 3 / H 2 O /的Et 3 N有被发现。通过这种简单方便的方法,在无溶剂条件下用微波辐照,可以实现各种硫代羰基化合物(如硫代酰胺,硫代内酰胺,硫代酮,噻吨酮和硫代rid啶酮)的清洁,快速,高效合成。
    DOI:
    10.1021/jo7022069
  • 作为产物:
    参考文献:
    名称:
    Utility of Complementary Molecular Reactivity and Molecular Recognition (CMR/R) Technology and Polymer-Supported Reagents in the Solution-Phase Synthesis of Heterocyclic Carboxamides
    摘要:
    The use of our recently reported chemical library purification strategy in the development of a herbicidal lead, N-(3-benzoylphenyl)-3-(1,1-dimethylethyl)-1-methyl-1H-pyrazole-5-carboxamide (3), is described. The approach applying fundamental properties of complementary molecular reactivity and molecular recognition (CMR/R) as the basis for a general purification strategy was utilized. Polymeric reagents were used in the synthesis to generate reactive species involved in product formation, and complementary molecular reactivity/molecular recognition polymer 8 (CMR/R polymer 8) was used in the solution-phase syntheses of building blocks, primary libraries, and lead refinement libraries. An extension of the CMR/R methodology was applied, utilizing a sequestration enabling reagent (SER), transforming a reactant into an electrophilic species sequestrable by CMR/R polymer 8. This library purification strategy enabled rapid lead generation and lead refinement to afford herbicide 27o. The CMR/R solid-phase purification technique enabled a simple, general, and powerful protocol, eliminating the usual tedious and time-consuming methods required for solution-phase product purification. The result was the synthesis of hundreds of compounds, prepared in a relatively short time, leading to a compound with a 4-fold improvement in herbicidal activity over the initial lead.
    DOI:
    10.1021/jo970571i
点击查看最新优质反应信息

文献信息

  • Sulphonamides derived from diarylmethanes, the processes for preparing
    申请人:SANOFI
    公开号:US04980349A1
    公开(公告)日:1990-12-25
    The invention relates to new compounds corresponding to formula I: ##STR1## in which: W represents C=O, CH.sub.2 or CHOH, Z represents ##STR2## R.sub.1 and R.sub.2 represent especially Cl or F, R, R' and R" represent especially H, X represents especially CH.sub.2, Y represents especially COOH, u and v are two integers ranging from 0 to 10, p and q take the value 0 or 1, n and m are two integers ranging 0 to 10 and t is 0 or 1 the total number of carbon atoms in the chain ##STR3## ranging from 2 to 20, and to their physiologically acceptable salts obtained with organic or inorganic acids. These compounds are useful for preparing medicinal products which have, especially, anti-inflammatory properties.
    该发明涉及与以下式I相对应的新化合物:##STR1## 其中:W代表C=O、CH.sub.2或CHOH,Z代表##STR2## R.sub.1和R.sub.2特别代表Cl或F,R、R'和R"特别代表H,X特别代表CH.sub.2,Y特别代表COOH,u和v是从0到10的两个整数,p和q取值为0或1,n和m是从0到10的两个整数,t为0或1链中的碳原子总数##STR3##范围从2到20,并且它们与有机或无机酸获得的生理上可接受的盐。这些化合物可用于制备具有特别抗炎性能的药物制剂。
  • Trisubstituted carbocyclic cyclophilin binding compounds and their use
    申请人:——
    公开号:US20020165275A1
    公开(公告)日:2002-11-07
    The present invention relates to novel, non-peptidic small organic compounds having an affinity for cyclophilin (CyP)-type immunophilin proteins, and to pharmaceutical compositions comprising one or more of the said compounds. The invention further relates to the uses of these compounds and compositions for binding CyP-type proteins, inhibiting their peptidyl-prolyl isomerase activity, and for research, development, and therapeutic applications in a variety of medical disorders.
    本发明涉及一种新型的非肽类小有机化合物,其具有与环肽亚精蛋白(CyP)型免疫蛋白亲和力,并且涉及包含所述化合物中的一个或多个的药物组合物。该发明还涉及这些化合物和组合物用于结合CyP型蛋白,抑制其肽基脯氨酸异构酶活性,并在各种医学疾病的研究、开发和治疗应用中的用途。
  • Potentiators of glutamate receptors
    申请人:——
    公开号:US20040006114A1
    公开(公告)日:2004-01-08
    The present invention relates to potentiators of metabotropic glutamate receptor function and specifically provides compounds of formula I, compositions thereof and methods of using the same. 1
    本发明涉及代谢型谷氨酸受体功能的增强剂,具体提供了化合物I的公式、其组合物以及使用方法。
  • Exploring the influence of designer surfactant hydrophobicity in key C C/C N bond forming reactions
    作者:Singarajanahalli Mundarinti Krishna Reddy、Jagatheeswaran Kothandapani、Megarajan Sengan、Anbazhagan Veerappan、Subramaniapillai Selva Ganesan
    DOI:10.1016/j.mcat.2019.01.006
    日期:2019.3
    aqueous medium via 5-exo-trig cyclization reaction. The scope of the reaction was extended to intermolecular Csp2-Csp2 and Csp2-N bond forming reactions in water. Systematic investigations revealed that altering hydrophobicity of surfactant influences the yield of both CC and CN bond forming reactions in water.
    探索了设计胶束介质,以通过5-exo-trig环化反应在水性介质中将各种苯胺转化为相应的密集取代的生物学相关的粪臭素衍生物。反应的范围扩展到在水中的分子间Csp 2 -Csp 2和Csp 2 -N键形成反应。系统研究表明,改变表面活性剂的疏水性会影响水中C C和C N键形成反应的产率。
  • CARROLL, R. D.;MILLER, M. W.;MYLARI, B. L.;CHAPPEL, L. R.;HOWES, H. L. ,,+, J. MED. CHEM., 1983, 26, N 1, 96-100
    作者:CARROLL, R. D.、MILLER, M. W.、MYLARI, B. L.、CHAPPEL, L. R.、HOWES, H. L. ,,+
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐